CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Andere talen Charles River Laboratories International, Inc.

Aandelen

CRL

US1598641074

Beurs gesloten - Nyse Andere beurzen 22:00:02 23-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
240,1 ^USD	+3,26%		+3,35%	+1,58%

16/04	Charles River Laboratories lanceert Alternative Methods Advancement Project om afhankelijkheid van dierproeven te verminderen	CI
12/04	CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : Zacks Investment Research is neutraal gestemd over het aandeel	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally	22/04
Charles River Laboratories International : 2023 Corporate Citizenship Report	22/04
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing	16/04
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing	16/04
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call	15/04
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call	12/04
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology	11/04
Charles River Laboratories International, Inc. and Deciphex Limited Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology	11/04
Charles River Laboratories, Axovia Therapeutics Collaborate on Developing Rare Disease Gene Therapies	09/04
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics	09/04
Charles River Laboratories International, Inc. Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics	09/04
Charles River Laboratories Signs Plasmid DNA Manufacturing Deal With Ship of Theseus	04/04
Charles River to Perform Plasmid Production for Ship of Theseus	04/04
Charles River to Perform Plasmid Production for Ship of Theseus	04/04
Charles River Laboratories International, Inc. and Ship of Theseus Announces Good Manufacturing Practice Plasmid DNA Contract Development and Manufacturing Organization Agreement	04/04
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024	01/04
Charles River Laboratories International, Inc Receives a Shareholder Proposal from People for the Ethical Treatment of Animals	29/03
Charles River Laboratories Publishes 2023 Corporate Citizenship Report	27/03
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine	21/03
Charles River Laboratories International, Inc. Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine	21/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Charles River Laboratories International, Inc.

Aandelen

CRL

US1598641074

Andere talen

Filters